Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Nov;72(5):1138–1143. doi: 10.1038/bjc.1995.477

Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).

S Dessì 1, B Batetta 1, O Spano 1, G J Bagby 1, L Tessitore 1, P Costelli 1, F M Baccino 1, P Pani 1, J M Argilès 1
PMCID: PMC2033925  PMID: 7577459

Abstract

Rats transplanted with the ascites hepatoma Yoshida AH-130 developed a severely progressive cachexia, characterised by marked alterations in protein and lipid metabolism. In particular, high levels of serum triglycerides and free fatty acids were associated with altered levels and distribution of plasma cholesterol, with increased total and very low-density lipoprotein-low-density lipoprotein (VLDL-LDL) cholesterol and reduced high-density lipoprotein (HDL) cholesterol. The tumour cells showed high rates of cholesterol synthesis and elevated content of free and esterified cholesterol, whereas total cholesterol synthesis was reduced in the host liver. To determine whether these perturbations could be related to the elevation of tumour necrosis factor alpha (TNF-alpha) previously shown in the AH-130 bearers (Tessitore L, Costelli P, Baccino FM 1993, Br J Cancer, 67, 15-23), either anti-TNF polyclonal antibodies or non-immune IgGs were injected daily after tumour transplantation. The anti-TNF treatment neither affected tumour growth nor prevented the serum cholesterol changes, while attenuating the hypertriglyceridaemia and the elevated serum free fatty acid levels. These data indicate that TNF does not appear to be directly involved in the altered cholesterol metabolism in AH-130 hosts, thus supporting the view that cholesterol metabolism and lipid metabolism are regulated differently during tumour growth.

Full text

PDF
1138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. G., Brown M. S., Goldstein J. L. Inefficient internalization of receptor-bound low density lipoprotein in human carcinoma A-431 cells. J Cell Biol. 1981 Feb;88(2):441–452. doi: 10.1083/jcb.88.2.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOWMAN R. E., WOLF R. C. A rapid and specific ultramicro method for total serum cholesterol. Clin Chem. 1962 May-Jun;8:302–309. [PubMed] [Google Scholar]
  3. Bagby G. J., Plessala K. J., Wilson L. A., Thompson J. J., Nelson S. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis. 1991 Jan;163(1):83–88. doi: 10.1093/infdis/163.1.83. [DOI] [PubMed] [Google Scholar]
  4. Bani I. A., Williams C. M., Boulter P. S., Dickerson J. W. Plasma lipids and prolactin in patients with breast cancer. Br J Cancer. 1986 Sep;54(3):439–446. doi: 10.1038/bjc.1986.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beutler B., Cerami A. The history, properties, and biological effects of cachectin. Biochemistry. 1988 Oct 4;27(20):7575–7582. doi: 10.1021/bi00420a001. [DOI] [PubMed] [Google Scholar]
  6. Boer G. J. A simplified microassay of DNA and RNA using ethidium bromide. Anal Biochem. 1975 May 12;65(1-2):225–231. doi: 10.1016/0003-2697(75)90507-2. [DOI] [PubMed] [Google Scholar]
  7. Carbó N., Costelli P., Tessitore L., Bagby G. J., López-Soriano F. J., Baccino F. M., Argilés J. M. Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci (Lond) 1994 Sep;87(3):349–355. doi: 10.1042/cs0870349. [DOI] [PubMed] [Google Scholar]
  8. Clark R. W., Crain R. C. Characterization of alterations in plasma lipoprotein lipid and apoprotein profiles accompanying hepatoma-induced hyperlipidemia in rats. Cancer Res. 1986 Apr;46(4 Pt 2):1894–1903. [PubMed] [Google Scholar]
  9. Coleman P. S., Lavietes B. B. Membrane cholesterol, tumorigenesis, and the biochemical phenotype of neoplasia. CRC Crit Rev Biochem. 1981;11(4):341–393. doi: 10.1080/10409238109104421. [DOI] [PubMed] [Google Scholar]
  10. Costelli P., Carbó N., Tessitore L., Bagby G. J., Lopez-Soriano F. J., Argilés J. M., Baccino F. M. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest. 1993 Dec;92(6):2783–2789. doi: 10.1172/JCI116897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Daniels R. J., Guertler L. S., Parker T. S., Steinberg D. Studies on the rate of efflux of cholesterol from cultured human skin fibroblasts. J Biol Chem. 1981 May 25;256(10):4978–4983. [PubMed] [Google Scholar]
  12. Dessì S., Batetta B., Pulisci D., Accogli P., Pani P., Broccia G. Total and HDL cholesterol in human hematologic neoplasms. Int J Hematol. 1991 Dec;54(6):483–486. [PubMed] [Google Scholar]
  13. Dessì S., Batetta B., Pulisci D., Spano O., Anchisi C., Tessitore L., Costelli P., Baccino F. M., Aroasio E., Pani P. Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer. 1994 Jan 15;73(2):253–258. doi: 10.1002/1097-0142(19940115)73:2<253::aid-cncr2820730204>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  14. Dessì S., Chiodino C., Batetta B., Fadda A. M., Anchisi C., Pani P. Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp Mol Pathol. 1986 Apr;44(2):169–176. doi: 10.1016/0014-4800(86)90067-5. [DOI] [PubMed] [Google Scholar]
  15. Dessí S., Batetta B., Anchisi C., Pani P., Costelli P., Tessitore L., Baccino F. M. Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer. 1992 Nov;66(5):787–793. doi: 10.1038/bjc.1992.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dessí S., Batetta B., Carrucciu A., Pulisci D., Laconi S., Fadda A. M., Anchisi C., Pani P. Variations of serum lipoproteins during cell proliferation induced by lead nitrate. Exp Mol Pathol. 1989 Oct;51(2):97–102. doi: 10.1016/0014-4800(89)90010-5. [DOI] [PubMed] [Google Scholar]
  17. Dietschy J. M., Turley S. D., Spady D. K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res. 1993 Oct;34(10):1637–1659. [PubMed] [Google Scholar]
  18. Eisenberg S. High density lipoprotein metabolism. J Lipid Res. 1984 Oct;25(10):1017–1058. [PubMed] [Google Scholar]
  19. Ettinger W. H., Miller L. D., Albers J. J., Smith T. K., Parks J. S. Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys. J Lipid Res. 1990 Jun;31(6):1099–1107. [PubMed] [Google Scholar]
  20. Evans R. D., Argilés J. M., Williamson D. H. Metabolic effects of tumour necrosis factor-alpha (cachectin) and interleukin-1. Clin Sci (Lond) 1989 Oct;77(4):357–364. doi: 10.1042/cs0770357. [DOI] [PubMed] [Google Scholar]
  21. Evans R. D., Williamson D. H. Tumour necrosis factor alpha (cachectin) mimics some of the effects of tumour growth on the disposal of a [14C]lipid load in virgin, lactating and litter-removed rats. Biochem J. 1988 Dec 15;256(3):1055–1058. doi: 10.1042/bj2561055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  23. Feingold K. R., Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987 Jul;80(1):184–190. doi: 10.1172/JCI113046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Feingold K. R., Hardardottir I., Memon R., Krul E. J., Moser A. H., Taylor J. M., Grunfeld C. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res. 1993 Dec;34(12):2147–2158. [PubMed] [Google Scholar]
  25. Feingold K. R., Staprans I., Memon R. A., Moser A. H., Shigenaga J. K., Doerrler W., Dinarello C. A., Grunfeld C. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992 Dec;33(12):1765–1776. [PubMed] [Google Scholar]
  26. Grunfeld C., Wilking H., Neese R., Gavin L. A., Moser A. H., Gulli R., Serio M. K., Feingold K. R. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res. 1989 May 15;49(10):2554–2560. [PubMed] [Google Scholar]
  27. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Harada K., Shimano H., Kawakami M., Ishibashi S., Gotoda T., Mori N., Takaku F., Yamada N. Effect of tumor necrosis factor/cachectin on the activity of the low density lipoprotein receptor on human skin fibroblasts. Biochem Biophys Res Commun. 1990 Nov 15;172(3):1022–1027. doi: 10.1016/0006-291x(90)91548-7. [DOI] [PubMed] [Google Scholar]
  29. Kannan R., Baker N. Hypertriglyceridemia in Ehrlich ascites carcinomatous mice: tumor and mouse strain differences. Lipids. 1977 Feb;12(2):153–158. doi: 10.1007/BF02533286. [DOI] [PubMed] [Google Scholar]
  30. Kawakami M., Pekala P. H., Lane M. D., Cerami A. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci U S A. 1982 Feb;79(3):912–916. doi: 10.1073/pnas.79.3.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  32. Okazaki M., Ohno Y., Hara I. High-performance aqueous gel permeation chromatography of human serum lipoproteins. J Chromatogr. 1980 Dec 12;221(2):257–264. doi: 10.1016/s0378-4347(00)84310-8. [DOI] [PubMed] [Google Scholar]
  33. Oram J. F., Johnson C. J., Brown T. A. Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization. J Biol Chem. 1987 Feb 15;262(5):2405–2410. [PubMed] [Google Scholar]
  34. Pape M. E., Kim K. H. Effect of tumor necrosis factor on acetyl-coenzyme A carboxylase gene expression and preadipocyte differentiation. Mol Endocrinol. 1988 May;2(5):395–403. doi: 10.1210/mend-2-5-395. [DOI] [PubMed] [Google Scholar]
  35. Pekala P. H., Kawakami M., Angus C. W., Lane M. D., Cerami A. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci U S A. 1983 May;80(9):2743–2747. doi: 10.1073/pnas.80.9.2743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pekala P. H., Price S. R., Horn C. A., Hom B. E., Moss J., Cerami A. Model for cachexia in chronic disease: secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L1 adipocytes. Trans Assoc Am Physicians. 1984;97:251–259. [PubMed] [Google Scholar]
  37. Reverter J. C., Sierra J., Martí-Tutusaus J. M., Montserrat E., Grañena A., Rozman C. Hypocholesterolemia in acute myelogenous leukemia. Eur J Haematol. 1988 Oct;41(4):317–320. doi: 10.1111/j.1600-0609.1988.tb00203.x. [DOI] [PubMed] [Google Scholar]
  38. Rössner S., Wallgren A. Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis. 1984 Sep;52(3):339–346. doi: 10.1016/0021-9150(84)90064-9. [DOI] [PubMed] [Google Scholar]
  39. Semb H., Peterson J., Tavernier J., Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem. 1987 Jun 15;262(17):8390–8394. [PubMed] [Google Scholar]
  40. Starnes H. F., Jr, Warren R. S., Jeevanandam M., Gabrilove J. L., Larchian W., Oettgen H. F., Brennan M. F. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest. 1988 Oct;82(4):1321–1325. doi: 10.1172/JCI113733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tessitore L., Bonelli G., Baccino F. M. Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J. 1987 Jan 1;241(1):153–159. doi: 10.1042/bj2410153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tessitore L., Costelli P., Baccino F. M. Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer. 1993 Jan;67(1):15–23. doi: 10.1038/bjc.1993.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Tessitore L., Costelli P., Baccino F. M. Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer. 1993 Jan;67(1):15–23. doi: 10.1038/bjc.1993.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Torti F. M., Dieckmann B., Beutler B., Cerami A., Ringold G. M. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science. 1985 Aug 30;229(4716):867–869. doi: 10.1126/science.3839597. [DOI] [PubMed] [Google Scholar]
  45. VAN HANDEL E., ZILVERSMIT D. B. Micromethod for the direct determination of serum triglycerides. J Lab Clin Med. 1957 Jul;50(1):152–157. [PubMed] [Google Scholar]
  46. Vitols S., Gahrton G., Björkholm M., Peterson C. Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet. 1985 Nov 23;2(8465):1150–1154. doi: 10.1016/s0140-6736(85)92679-0. [DOI] [PubMed] [Google Scholar]
  47. Yachnin S., Larson R. A., West E. J. Rates of cholesterol biosynthesis are related to early differentiation in acute non-lymphocytic leukaemia cells. Br J Haematol. 1983 Jul;54(3):459–466. doi: 10.1111/j.1365-2141.1983.tb02120.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES